Cargando…

Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction

BACKGROUND: The clinical treatment of coronary microvascular dysfunction (CMD) is mainly based on conventional medicine, but the mechanism of the medicine is single and the efficacy is different. Shenmai injection (SMI) has a variety of ingredients, but the effect of SMI on CMD has not been studied....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Zhaohai, Yu, Zhangjie, Xu, Buyun, Zhou, Yan, Xing, Yangbo, Li, Qingsong, Tang, Weiliang, Peng, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203227/ https://www.ncbi.nlm.nih.gov/pubmed/35722150 http://dx.doi.org/10.1155/2022/8630480

Ejemplares similares

Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
por: Li, Lin, et al.
Publicado: (2020)

An Overview of Systematic Reviews of Shenmai Injection for Healthcare
por: Lu, Ling-yan, et al.
Publicado: (2014)

Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy
por: Xu, Buyun, et al.
Publicado: (2020)

Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients with Heart failure: A Meta-Analysis of Randomized Controlled Trials
por: Yu, Zhangjie, et al.
Publicado: (2022)

Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation
por: Li, Lin, et al.
Publicado: (2020)

Quality monitoring of Shenmai injection by HPLC pharmacodynamic fingerprinting
por: Yang, Geng, et al.
Publicado: (2023)

Anaphylactoid reactions induced by Shuanghuanglian injection and Shenmai injection and metabolomics analysis
por: Zhang, Chi, et al.
Publicado: (2023)

Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators
por: Zhang, Sheng, et al.
Publicado: (2019)

The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention
por: Zhao, Jingjing, et al.
Publicado: (2020)

P2Y12 inhibitor pretreatment in patients with nonST-segment elevation acute coronary syndrome: A meta-analysis
por: Yan, Longhui, et al.
Publicado: (2022)

Comparison of Protective Effects of Shenmai Injections Produced by Medicinal Materials from Different Origins on Cardiomyocytes
por: Zhao, Min, et al.
Publicado: (2022)

Effects of Shenmai injection and its bioactive components following ischemia/reperfusion in cardiomyocytes
por: YE, LI-FANG, et al.
Publicado: (2015)

Effect of Shenmai injection on preventing the development of nitroglycerin-induced tolerance in rats
por: Zhou, Qian, et al.
Publicado: (2017)

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
por: Zheng, Zhaohai, et al.
Publicado: (2020)

Adjuvant Application of Shenmai Injection for Sepsis: A Systematic Review and Meta-Analysis
por: Sun, Ye, et al.
Publicado: (2022)

Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
por: Wang, Shao-mei, et al.
Publicado: (2020)

Authentication and distinction of Shenmai injection with HPLC fingerprint analysis assisted by pattern recognition techniques
por: Lu, Xue-Feng, et al.
Publicado: (2012)

Efficacy of Shenmai injection for the treatment of chronic heart failure: A protocol of systematic review
por: Gao, Peng, et al.
Publicado: (2020)

Coronary Microvascular Dysfunction
por: Vancheri, Federico, et al.
Publicado: (2020)

The effect of Shenmai injection on the proliferation of Rat airway smooth muscle cells in asthma and underlying mechanism
por: Zhao, Limin, et al.
Publicado: (2013)

Therapeutic efficacy of shenmai injection as an adjuvant treatment in dilated cardiomyopathy: A protocol for systematic review
por: Gao, Kai, et al.
Publicado: (2020)

Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics
por: Zhong, Chongjin, et al.
Publicado: (2020)

The Neuroprotective Effect of Shenmai Injection on Oxidative Stress Injury in PC12 Cells Based on Network Pharmacology
por: Wu, Jing, et al.
Publicado: (2022)

Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice
por: Zhang, Shiyu, et al.
Publicado: (2022)

Inflammation in Coronary Microvascular Dysfunction
por: Sagris, Marios, et al.
Publicado: (2021)

Effects of Shenmai injection on the values of CO, SV, and EF in patients undergoing off-pump coronary artery bypass graft: A randomized, clinical trial
por: Liu, Qingxue, et al.
Publicado: (2018)

Shenmai injection as an adjuvant treatment for chronic cor pulmonale heart failure: a systematic review and meta-analysis of randomized controlled trials
por: Shi, Liwei, et al.
Publicado: (2015)

Efficacy and Safety of a Combination of Shenmai Injection plus Chemotherapy for the Treatment of Lung Cancer: A Meta-Analysis
por: Qin, Guo-wei, et al.
Publicado: (2021)

The clinical efficacy of Shenmai injection in the prophylaxis and treatment of intradialytic hypotension: A protocol for systematic review and meta-analysis
por: Xiang, Zhen, et al.
Publicado: (2022)

Network analysis to explore the pharmacological mechanism of Shenmai injection in treating granulocytopenia and evidence-based medicine approach validation
por: Hou, Xianbing, et al.
Publicado: (2023)

Pretreatment with Danhong injection protects the brain against ischemia-reperfusion injury
por: Wang, Shaoxia, et al.
Publicado: (2014)

Erratum to: Shenmai injection as an adjuvant treatment for chronic cor pulmonale heart failure: a systematic review and meta-analysis of randomized controlled trials
por: Shi, Liwei, et al.
Publicado: (2015)

Coronary microvascular dysfunction in diabetes mellitus
por: Kibel, Aleksandar, et al.
Publicado: (2017)

Invasive evaluation of coronary microvascular dysfunction
por: Travieso, Alejandro, et al.
Publicado: (2022)

Circulating Biomarkers in Coronary Microvascular Dysfunction
por: Chakrala, Teja, et al.
Publicado: (2023)

Ginsenoside Rb1 and Rd Remarkably Inhibited the Hepatic Uptake of Ophiopogonin D in Shenmai Injection Mediated by OATPs/oatps
por: Liu, Xiaopei, et al.
Publicado: (2018)

Effect of Shenmai injection on cognitive function after cardiopulmonary bypass in cardiac surgical patients: a randomized controlled trial
por: Chen, Lei, et al.
Publicado: (2018)

Anti-Inflammatory Effects and Molecular Mechanisms of Shenmai Injection in Treating Acute Pancreatitis: Network Pharmacology Analysis and Experimental Verification
por: He, Yanqiu, et al.
Publicado: (2022)

Shenmai injection ameliorates doxorubicin-induced myocardial injury by suppressing autophagy-apoptosis via miR-30a
por: Li, Yanyang, et al.
Publicado: (2023)

Coronary Microvascular Dysfunction: Linking Inflammation and Cardiac Dysfunction?
por: Schindler, Thomas H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qd50a6hkknt9ltd66b4oq4bskl